Innovative Solutions Unveiled: Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service for Efficient Pharmaceutical Manufacturing
In a strategic move aimed at reshaping the landscape of pharmaceutical manufacturing, Stevanato Group has introduced two groundbreaking offerings – the EZ-fill® Kit and a non-GMP laboratory fill and finish service. Positioned as key components in the company’s commitment to advancing small-batch pharmaceutical manufacturing, these innovations aim to streamline processes, enhance efficiency, and accelerate drug development timelines.
The EZ-fill® Kit, a star in Stevanato Group’s latest offerings, emerges as a game-changer for pharma and biotech companies engaged in small-batch manufacturing during clinical trials or commercial phases. Recognizing the critical importance of reducing time-to-market, this customizable and versatile solution provides swift access for filling small batches with high-quality injectable formulations. Leveraging the advantages of a ready-to-use platform featuring pre-sterilized containment solutions like vials, cartridges, and syringes, the EZ-fill® Kit offers a modular approach. It allows customers to effectively screen various primary packaging options in conjunction with drug products, thereby enhancing levels of quality and safety throughout the drug life cycle.
Complementing the EZ-fill® Kit is Stevanato Group’s non-GMP laboratory fill and finish service, strategically located at its Technology Excellence Centers (TEC) in Boston, USA, and Piombino Dese, Italy. This service provides customers with a valuable opportunity to assess and identify potential impacts of the fill-and-finish process on product performance, right from the container selection stage. By offering this non-GMP laboratory service, Stevanato Group aims to de-risk processes, empower development strategies, and foster a deeper understanding of the effects of the manufacturing process on the final product.
Fabio Bertacchini, Senior Director EZ-fill® Vials & Cartridges at Stevanato Group, highlighted the company’s commitment to supporting pharmaceutical innovation. “In the race to bring new advanced biopharmaceutical products to market and to patients, Stevanato Group is tackling the challenge of supporting customers with flexible drug containment and filling solutions in a timely manner,” Bertacchini stated. The company, through its global TEC Centers, is dedicated to elevating pharmaceutical manufacturing standards and assisting customers in navigating the complexities of the drug development journey.
As pharmaceutical companies strive to bring advanced products to market rapidly, Stevanato Group’s innovative solutions position them at the forefront of industry advancements. By providing flexible, efficient, and de-risked manufacturing options, the company aims to empower pharmaceutical innovators in making informed decisions throughout their drug development endeavors.
Source: GlassBalkan